Advanced Cell Technology is immediately initiating a Phase I/II multicenter clinical trial using retinal cells derived from human embryonic stem cells (hESCs) to treat patients with Stargardt's Macular Dystrophy (SMD). (Link to this FDA gives clearance to Advanced Cell Technology, for their First Clinical Trial)

What do you think about this?